ENDV OTC
Endonovo Therapeutics, Inc.
1W: +0.0%
1M: -50.0%
3M: -50.0%
YTD: -50.0%
1Y: -50.0%
3Y: -99.6%
5Y: -99.8%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
-100.0% YoY
$-3M
Net Income
+33.1% YoY
$0M
Free Cash Flow
-99.5% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE9.2%
ROA-1412.0%
ROIC4.5%
Valuation
P/E-0.1
P/B-0.0
EV/EBITDA-7.0
Leverage
Debt/Equity-0.23
Current Ratio0.00
Interest Cov.-1.1x
Quality Scores
Piotroski F3/9
Altman Z-3220.32
Beneish M0.00